For many high-growth European-based technology and life science entreprises, the United States is the most attractive country for expansion and/or later-stage fundraising. The U.S. offers the promise of massive commercial opportunities, cooperation partnerships and plentiful venture and growth capital. However, doing business and raising money in an unfamiliar, highly-competitive environment requires thoughtful advance planning and clinical execution.  

In this facilitated presentation and Q&A to follow, we will discuss best practices for navigating the logistical aspects of launching and operating a business in America and setting and meeting expectations for U.S. later-stage funding.

We will cover a number of frequently asked questions, such as:

• When should I consider establishing U.S. operations?
• When should I look to raise money from U.S. VCs?
• Do I need a U.S. company to raise money from U.S. VCs?
• When do I need to create a U.S. company? 
• What is a flip? How difficult is it to organize?
• Where is the best place to set up in the States?
• How long does U.S. set up take and how much does it cost?
• How do I sell/pitch in the U.S. as a non-U.S. founder?
• How is hiring different in the U.S., and what’s the optimal U.S. team?
• Does everyone really sue each other all the time in the U.S.? Is there any method to limit our liability?
• Are there U.S. government resources to assist with U.S. expansion?

To help you formulate any questions about U.S. expansion, scaling, fundraising, and exiting, visit our U.S. Expansion and Fundraising FAQ and our U.S. Expansion & Resources Library.